Cargando…
Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy
The X-linked genetic Fabry disease causes multiorgan lesions due to intracellular storage of the substrate globotriaosylceramide. Neurological involvement ranges from painful, small fiber neuropathy to cerebrovascular disorders to multifocal aggressive forms. Disease identification through proper di...
Autores principales: | Salviati, Alessandro, Burlina, Alessandro P., Borsini, Walter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869001/ https://www.ncbi.nlm.nih.gov/pubmed/20300794 http://dx.doi.org/10.1007/s10072-009-0211-y |
Ejemplares similares
-
FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of
clinical stabilization in Fabry disease
por: Mignani, Renzo, et al.
Publicado: (2016) -
Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience
por: Gragnaniello, Vincenza, et al.
Publicado: (2021) -
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel
por: Burlina, Alessandro P, et al.
Publicado: (2011) -
Fabry disease in children and the effects of enzyme replacement treatment
por: Pintos-Morell, Guillem, et al.
Publicado: (2009) -
Cost-effectiveness of enzyme replacement therapy for Fabry disease
por: Rombach, Saskia M, et al.
Publicado: (2013)